GENERAL AND SPECIAL EDUCATORS’ LEVEL OF PREPAREDNESS IN SUPPORTING STUDENTS WITH MENTAL HEALTH AND BEHAVIORAL CHALLENGES

Students with EBD and/or mental health challenges require access to sound behavioral support from “bell to bell�. However, due to lack of educator training, this need is often unmet. The purpose of this study is to obtain current data on the preparedness of general and special educators in order to better recognize and move toward filling in these support gaps. This is to benefit students with, or at-risk for behavior and/or mental health disorders, and teachers responsible for providing support. With the inadequacy of pre-service teacher training on supporting students with any sort of behavior challenge, a lack of resources including individuals with knowledge for consultation, and overall general education classroom hardships, it is not surprising that students with EBD and those with some of the highest level of behavioral needs would remain on an unchanged trajectory. A survey was conducted to gauge educators’ preparedness in supporting students requiring behavior support. Results, implications, and suggestions for future research will be provided

Screening of Chlamydia trachomatis in Pregnant Patients in the Emergency Department: A Pilot Study

The overall rate of Chlamydia trachomatis in pregnant women in the United States was found to be 1843 per 100,000 births from 2016 to 2018 and had a 2% increase from 2016 to 2018. Untreated Chlamydia infection of the cervix in pregnant women can be transmitted vertically and lead to preventable adverse birth outcomes including preterm delivery, low birth weight, neonatal conjunctivitis, and neonatal pneumonia. Current recommendations from the CDC include screening of all pregnant women <25 years of age and older pregnant women at increased risk for infection at the first prenatal visit, in addition to rescreening in the third trimester if <25 years of age or if the patient is at continued high risk. The emergency  department (ED) is a point of contact for prenatal care, especially for many patients whohave not yet seen a provider or may be unable to; however, no formal guidelines from the American College of Emergency Physicians (ACEP) exist as to when to screen for chlamydia in the ED setting

The neuroscience of social feelings:mechanisms of adaptive social functioning

Social feelings have conceptual and empirical connections with affect and emotion. In this review, we discuss how they relate to cognition, emotion, behavior and well-being. We examine the functional neuroanatomy and neurobiology of social feelings and their role in adaptive social functioning. Existing neuroscience literature is reviewed to identify concepts, methods and challenges that might be addressed by social feelings research. Specific topic areas highlight the influence and modulation of social feelings on interpersonal affiliation, parent-child attachments, moral sentiments, interpersonal stressors, and emotional communication. Brain regions involved in social feelings were confirmed by meta-analysis using the Neurosynth platform for large-scale, automated synthesis of functional magnetic resonance imaging data. Words that relate specifically to social feelings were identfied as potential research variables. Topical inquiries into social media behaviors, loneliness, trauma, and social sensitivity, especially with recent physical distancing for guarding public and personal health, underscored the increasing importance of social feelings for affective and second person neuroscience research with implications for brain development, physical and mental health, and lifelong adaptive functioning

Using Genomic Sequencing for Classical Genetics in E. coli K12

We here develop computational methods to facilitate use of 454 whole genome shotgun sequencing to identify mutations in Escherichia coli K12. We had Roche sequence eight related strains derived as spontaneous mutants in a background without a whole genome sequence. They provided difference tables based on assembling each genome to reference strain E. coli MG1655 (NC_000913). Due to the evolutionary distance to MG1655, these contained a large number of both false negatives and positives. By manual analysis of the dataset, we detected all the known mutations (24 at nine locations) and identified and genetically confirmed new mutations necessary and sufficient for the phenotypes we had selected in four strains. We then had Roche assemble contigs de novo, which we further assembled to full-length pseudomolecules based on synteny with MG1655. This hybrid method facilitated detection of insertion mutations and allowed annotation from MG1655. After removing one genome with less than the optimal 20- to 30-fold sequence coverage, we identified 544 putative polymorphisms that included all of the known and selected mutations apart from insertions. Finally, we detected seven new mutations in a total of only 41 candidates by comparing single genomes to composite data for the remaining six and using a ranking system to penalize homopolymer sequencing and misassembly errors. An additional benefit of the analysis is a table of differences between MG1655 and a physiologically robust E. coli wild-type strain NCM3722. Both projects were greatly facilitated by use of comparative genomics tools in the CoGe software package (http://genomevolution.org/)

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

GENERAL AND SPECIAL EDUCATORS’ LEVEL OF PREPAREDNESS IN SUPPORTING STUDENTS WITH MENTAL HEALTH AND BEHAVIORAL CHALLENGES

Students with EBD and/or mental health challenges require access to sound behavioral support from “bell to bell”. However, due to lack of educator training, this need is often unmet. The purpose of this study is to obtain current data on the preparedness of general and special educators in order to better recognize and move toward filling in these support gaps. This is to benefit students with, or at-risk for behavior and/or mental health disorders, and teachers responsible for providing support. With the inadequacy of pre-service teacher training on supporting students with any sort of behavior challenge, a lack of resources including individuals with knowledge for consultation, and overall general education classroom hardships, it is not surprising that students with EBD and those with some of the highest level of behavioral needs would remain on an unchanged trajectory. A survey was conducted to gauge educators’ preparedness in supporting students requiring behavior support. Results, implications, and suggestions for future research will be provided

Sadness and environmental behaviours

This study examined whether inciting sadness on UBC students increased their likelihood of being more aware of their environmental behaviours and subsequently more willing to act environmentally friendly. The study began by asking participants to fill out a survey (specific to their condition), and was finished by presenting the participants with a Great Canadian Shoreline Cleanup sign-up sheet. The study contained two conditions. One condition was labelled the “emotional” condition and the other was labelled the “statistical” condition. The first hypothesis of the study was that the participants in the “emotion” condition would be more willing to engage in environmentally friendly behaviours, which was measured by examining how many boxes they checked on the environmental actions checklist. The second hypothesis was that the participants in the “emotion” condition would be more likely sign up for the Great Canadian Shoreline cleanup. The participants in this study were UBC students, who filled out the survey at the Life and the Nest Buildings on UBC campus. The results revealed that the participants in the “emotion” condition did not have an increased willingness to engage in more environmentally friendly behaviours. The results show that both stimulus have some amount of impact on the levels of concern per an individual. Additionally, the manipulation of emotion was found to increases participants levels of concern for the environment in both conditions. Disclaimer: “UBC SEEDS provides students with the opportunity to share the findings of their studies, as well as their opinions, conclusions and recommendations with the UBC community. The reader should bear in mind that this is a student project/report and is not an official document of UBC. Furthermore readers should bear in mind that these reports may not reflect the current status of activities at UBC. We urge you to contact the research persons mentioned in a report or the SEEDS Coordinator about the current status of the subject matter of a project/report.”Arts, Faculty ofScience, Faculty ofPsychology, Department ofResources, Environment and Sustainability (IRES), Institute forUnreviewedUndergraduat